Y. Kim

Progesterone Receptor A Stability Is Mediated by Glycogen Synthase Kinase-3β in the Brca1-deficient Mammary Gland*

Y. Li, Shaohui Wang, P. Hsu, 2013, The Journal of Biological Chemistry.

GSK-3β and PR-A stabilization in BRCA1-deficient cells

Y. Li, Shaohui Wang, P. Hsu, 2013 .

Antitumor agents 279. Structure-activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents.

Yizhou Dong, K. Lee, S. Morris-Natschke, 2011, Bioorganic & medicinal chemistry letters.

Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.

Yizhou Dong, K. Lee, S. Morris-Natschke, 2012, Journal of natural products.

Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors.

G. Mills, G. Hortobagyi, E. Stanbridge, 2008, Cancer research.

Mediated Mouse Mammary Tumors − Brca 1 / p 53 Cancer Stem Cells Contribute to Cisplatin Resistance in Updated

G. Mills, G. Hortobagyi, E. Stanbridge, 2008 .

Prevention of Brca1-Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist

Y. Li, Wen-Hwa Lee, Suh-Chin J. Lin, 2006, Science.

Efficacy and Mechanism of Antitumor Activity of an Antibody Targeting Transferrin Receptor 1 in Mouse Models of Human Multiple Myeloma

M. Penichet, O. Martínez-Maza, T. R. Daniels-Wells, 2018, The Journal of Immunology.